Extract notice to the Minister

Auro-Nintedanib

Common name / Subject : nintedanib (ésilate de)
Name of the manufacturer : Auro Pharma inc.
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des
médicaments - Médicament
d'exception

Evaluation published on February 04, 2026

Subscribe to our newsletter now

Subscription